<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE trials [
<!ELEMENT trials (trial+)>

<!ELEMENT trial (main,contacts,countries,criteria,health_condition_code,health_condition_keyword,intervention_code,
          intervention_keyword,primary_outcome,secondary_outcome,secondary_sponsor,secondary_ids,source_support,ethics_reviews)>

<!ELEMENT main (trial_id,utrn?,reg_name,date_registration,primary_sponsor,public_title,acronym?,scientific_title,scientific_acronym?,
          date_enrolment,type_enrolment,target_size,recruitment_status,url?,study_type,study_design,phase,hc_freetext?,i_freetext?,results_actual_enrolment,results_date_completed,results_url_link,results_summary,           results_date_posted,results_date_first_publication,results_baseline_char,results_participant_flow,results_adverse_events,results_outcome_measures,results_url_protocol,results_IPD_plan, results_IPD_description)>
<!ELEMENT trial_id (#PCDATA)>
<!ELEMENT utrn (#PCDATA)>
<!ELEMENT reg_name (#PCDATA)>
<!ELEMENT date_registration (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT primary_sponsor (#PCDATA)>
<!ELEMENT public_title (#PCDATA)>
<!ELEMENT acronym (#PCDATA)>
<!ELEMENT scientific_title (#PCDATA)>
<!ELEMENT scientific_acronym (#PCDATA)>
<!ELEMENT date_enrolment (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT type_enrolment (#PCDATA)>
<!ELEMENT target_size (#PCDATA)>
<!ELEMENT recruitment_status (#PCDATA)><!-- Pending,Recruiting,Suspended,Complete,Other -->
<!ELEMENT url (#PCDATA)>
<!ELEMENT study_type (#PCDATA)><!-- interventional,observational -->
<!ELEMENT study_design (#PCDATA)>
<!ELEMENT phase (#PCDATA)>
<!ELEMENT hc_freetext (#PCDATA)>
<!ELEMENT i_freetext (#PCDATA)>
<!ELEMENT results_actual_enrolment (#PCDATA)>
<!ELEMENT results_date_completed (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_url_link (#PCDATA)>
<!ELEMENT results_summary (#PCDATA)>
<!ELEMENT results_date_posted (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_date_first_publication (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_baseline_char (#PCDATA)>
<!ELEMENT results_participant_flow (#PCDATA)>
<!ELEMENT results_adverse_events (#PCDATA)>
<!ELEMENT results_outcome_measures (#PCDATA)>
<!ELEMENT results_url_protocol (#PCDATA)>
<!ELEMENT results_IPD_plan (#PCDATA)>
<!ELEMENT results_IPD_description (#PCDATA)>


<!ELEMENT contacts (contact+)>
<!ELEMENT contact (type,firstname,middlename,lastname,address,city,country1,zip,telephone,email,affiliation)>
<!ELEMENT type (#PCDATA)><!-- Public,Scientific -->
<!ELEMENT firstname (#PCDATA)>
<!ELEMENT middlename (#PCDATA)>
<!ELEMENT lastname (#PCDATA)>
<!ELEMENT address (#PCDATA)>
<!ELEMENT city (#PCDATA)>
<!ELEMENT country1 (#PCDATA)>
<!ELEMENT zip (#PCDATA)>
<!ELEMENT telephone (#PCDATA)>
<!ELEMENT email (#PCDATA)>
<!ELEMENT affiliation (#PCDATA)>

<!ELEMENT countries (country2+)>
<!ELEMENT country2 (#PCDATA)>

<!ELEMENT criteria (inclusion_criteria,agemin,agemax,gender,exclusion_criteria)>
<!ELEMENT inclusion_criteria (#PCDATA)>
<!ELEMENT agemin (#PCDATA)>
<!ELEMENT agemax (#PCDATA)>
<!ELEMENT gender (#PCDATA)>
<!ELEMENT exclusion_criteria (#PCDATA)>

<!ELEMENT health_condition_code (hc_code+)>
<!ELEMENT hc_code (#PCDATA)>

<!ELEMENT health_condition_keyword (hc_keyword+)>
<!ELEMENT hc_keyword (#PCDATA)>

<!ELEMENT intervention_code (i_code+)>
<!ELEMENT i_code (#PCDATA)>

<!ELEMENT intervention_keyword (i_keyword+)>
<!ELEMENT i_keyword (#PCDATA)>

<!ELEMENT primary_outcome (prim_outcome+)>
<!ELEMENT prim_outcome (#PCDATA)>

<!ELEMENT secondary_outcome (sec_outcome+)>
<!ELEMENT sec_outcome (#PCDATA)>

<!ELEMENT secondary_sponsor (sponsor_name+)>
<!ELEMENT sponsor_name (#PCDATA)>

<!ELEMENT secondary_ids (secondary_id+)>
<!ELEMENT secondary_id (sec_id,issuing_authority)>
<!ELEMENT sec_id (#PCDATA)>
<!ELEMENT issuing_authority (#PCDATA)>

<!ELEMENT source_support (source_name+)>
<!ELEMENT source_name (#PCDATA)>

<!ELEMENT ethics_reviews (ethics_review+)>
<!ELEMENT ethics_review (status,approval_date,contact_name,contact_address,contact_phone,contact_email)>
<!ELEMENT status (#PCDATA)><!-- Not approved,Approved,NA -->
<!ELEMENT approval_date (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT contact_name (#PCDATA)>
<!ELEMENT contact_address (#PCDATA)>
<!ELEMENT contact_phone (#PCDATA)>
<!ELEMENT contact_email (#PCDATA)>
]>
<trials>
  <trial>
    <main>
      <trial_id>IRCT20231021059788N1</trial_id>
      <utrn></utrn>
      <reg_name>IRCT</reg_name>
      <date_registration>2024-01-16</date_registration>
      <primary_sponsor>Islamic Azad University</primary_sponsor>
      <public_title>Comparison of the effect of V-One mouthwash (ginger) and Irsha mouthwash (ginger and yarrow) and nystatin in the treatment of denture osteomatitis type 2</public_title>
      <acronym></acronym>
      <scientific_title>Comparison of V-One mouthwash (ginger); Irsha (ginger and yarrow) and nystatin on the amount of oral mucosal erythema in people with denture stomatitis type 2: a clinical trial</scientific_title>
      <scientific_acronym></scientific_acronym>
      <date_enrolment>2024-01-20</date_enrolment>
      <type_enrolment>anticipated</type_enrolment>
      <target_size>54</target_size>
      <recruitment_status>Complete</recruitment_status>
      <url>https://irct.ir/trial/73269</url>
      <study_type>interventional</study_type>
      <study_design>Randomization: Randomized, Blinding: Double blinded, Placebo: Not used, Assignment: Parallel, Purpose: Treatment, Randomization description: Bottles that are completely similar in appearance to each other, are poured by one of the three drugs that is going to be examined in the study. For each drug there will be 18 bottles and each bottle suffices for use of a patient during one week and after one week it must be refilled. The bottles are numbered randomly from 1 to 54 and the characteristics of bottles are recorded in the database. A simple randomization method will be used. During the delivery of the medicine to the patient, random number generation software (Microsoft Excel 2013) will be used to assign a random number from 1 to 54 to each patient, and the person receives a bottle containing medicine with the corresponding number. Because it takes time to find related people to enter the study and their visit to the clinic for initial examination and required documentation and signing informed consent is done on different days, therefore, the people participating in the study do not have any contact with each other and hence allocation concealment is implemented in practice, Blinding description: Bottles containing mouthwash are already filled and numbered by the supervisor. The specifications of the mouthwash are recorded and kept by him in the sheet. The bottles containing the mouthwashes are completely similar in appearance and the contents of the bottles are not visible from the outside.</study_design>
      <phase>3</phase>
      <hc_freetext>Denture Stomatitis.</hc_freetext>
      <i_freetext>Intervention 1: Intervention group 1: use of Irsha's ginger and yarrow mouthwash. The concentration of effective ingredients is 25%. Five ml of mouthwash is swirled in the mouth 4 times a day for 3 minutes each time and then thrown away. Produced by Shafa Pharmaceutical Laboratory - Tehran - Iran. Intervention 2: Intervention group 2: use of ginger mouthwash V One. The concentration of effective ingredients is 25%. 5 ml of mouthwash is swirled in the mouth 4 times a day for 3 minutes each time and then thrown away. Produced by Rojin company. Tehran Iran. Intervention 3: Intervention group: Use of nystatin suspension. 100000 units. 5 ml of mouthwash is swirled in the mouth 4 times a day for 3 minutes each time and then thrown away. Produced by Jaber Bin Hayan Company - Tehran - Iran.</i_freetext>
      <results_actual_enrolment></results_actual_enrolment>
      <results_date_completed></results_date_completed>
      <results_url_link></results_url_link>
      <results_summary></results_summary>
      <results_date_posted></results_date_posted>
      <results_date_first_publication></results_date_first_publication>
      <results_baseline_char></results_baseline_char>
      <results_participant_flow></results_participant_flow>
      <results_adverse_events></results_adverse_events>
      <results_outcome_measures></results_outcome_measures>
      <results_url_protocol></results_url_protocol>
      <results_IPD_plan>No - There is not a plan to make this available</results_IPD_plan>
      <results_IPD_description>Justification or reason for not sharing IPD is There is no further information</results_IPD_description>
    </main>
    <contacts>
      <contact>
        <type>public</type>
        <firstname>Seyed Mohammad Zamaan Mousavi Kaani</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>No. 4; Nistan Dahom; Pasdaran street</address>
        <city>Tehran</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>19585/175</zip>
        <telephone>+98 21 2256 4571</telephone>
        <email>m.mousavik@gmail.com</email>
        <affiliation>Islamic Azad University</affiliation>
      </contact>
      <contact>
        <type>scientific</type>
        <firstname>Seyed Mohammad Zaamaan mousavi</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>No. 4; Nistan Dahom; Pasdaran street</address>
        <city>Tehran</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>19585/175</zip>
        <telephone>+98 21 2256 4571</telephone>
        <email>m.mousavik@gmail.com</email>
        <affiliation>Islamic Azad University</affiliation>
      </contact>
    </contacts>
    <countries>
      <country2>Iran (Islamic Republic of)</country2>
    </countries>
    <criteria>
      <inclusion_criteria>The presence of symptoms of oral candidiasis in the patient's palate
Being literate in reading and writing
Being able to use mouthwash</inclusion_criteria>
      <agemin>18 years</agemin>
      <agemax>no limit</agemax>
      <gender>Both</gender>
      <exclusion_criteria>Individuals who are allergic to ginger, yarrow and/or nystatin mouthwash
Individuals who have a diet rich in ginger
having diabetes
Having hypoparathyroidism
History of chemotherapy and radiotherapy
Use of antibiotics and antifungals during the last 4 weeks</exclusion_criteria>
    </criteria>
    <health_condition_code>
      <hc_code>K12</hc_code>
    </health_condition_code>
    <health_condition_keyword>
      <hc_keyword>Stomatitis and related lesions</hc_keyword>
    </health_condition_keyword>
    <intervention_code>
      <i_code>Treatment - Drugs</i_code>
      <i_code>Treatment - Drugs</i_code>
      <i_code>Treatment - Drugs</i_code>
    </intervention_code>
    <intervention_keyword>
      <i_keyword>Intervention group 1: use of Irsha's ginger and yarrow mouthwash. The concentration of effective ingredients is 25%. Five ml of mouthwash is swirled in the mouth 4 times a day for 3 minutes each time and then thrown away. Produced by Shafa Pharmaceutical Laboratory - Tehran - Iran</i_keyword>
      <i_keyword>Intervention group 2: use of ginger mouthwash V One. The concentration of effective ingredients is 25%. 5 ml of mouthwash is swirled in the mouth 4 times a day for 3 minutes each time and then thrown away. Produced by Rojin company. Tehran Iran</i_keyword>
      <i_keyword>Intervention group: Use of nystatin suspension. 100000 units. 5 ml of mouthwash is swirled in the mouth 4 times a day for 3 minutes each time and then thrown away. Produced by Jaber Bin Hayan Company - Tehran - Iran</i_keyword>
    </intervention_keyword>
    <primary_outcome>
      <prim_outcome>The area of erythema in the mucosa. Timepoint: Measurement of mucosal erythema area at the beginning of the study (before the intervention) and 7, 14 and 21 days after the start of mouthwash use. Method of measurement: Area measurement module in ImageJ image processing software.</prim_outcome>
    </primary_outcome>
    <secondary_outcome>
      <sec_outcome></sec_outcome>
    </secondary_outcome>
    <secondary_sponsor>
      <sponsor_name></sponsor_name>
    </secondary_sponsor>
    <secondary_ids>
      <secondary_id>
        <sec_id></sec_id>
        <issuing_authority></issuing_authority>
      </secondary_id>
    </secondary_ids>
    <source_support>
      <source_name>by myself</source_name>
    </source_support>
    <ethics_reviews>
      <ethics_review>
        <status>Approved</status>
        <approval_date>2023-10-14</approval_date>
        <contact_name>Ethics Committee of Faculty of Dentistry, Tehran Islamic Azad University of Medical Sciences</contact_name>
        <contact_address>No. 4; Nistan Dahom;  Pasdaran street Tehran Tehran Iran (Islamic Republic of)</contact_address>
        <contact_phone></contact_phone>
        <contact_email></contact_email>
      </ethics_review>
    </ethics_reviews>
  </trial>
</trials>
